Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
GSK-324332A by GSK for Herpes Zoster (Shingles): Likelihood of Approval
GSK-324332A is under clinical development by GSK and currently in Phase III for Herpes Zoster (Shingles). According to GlobalData, Phase...